Amedisys Inc.

United States of America Country flag United States of America
Sector: Health Care Providers
Ticker: AMED
Factsheet Factsheet

Market multiple valuation of Amedisys Inc. ( AMED | USA)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of Amedisys Inc. is lower than the median of its peer group: around 21.00. The company valuation of Amedisys Inc. according to these metrics is below the market valuation of its peer group.
The P/Earnings NTM ratio of Amedisys Inc. is significantly higher than the average of its sector (Health Care Providers): 14.10. The company valuation of Amedisys Inc. according to these metrics is way above the market valuation of its sector.
The P/Earnings NTM ratio of Amedisys Inc. is significantly lower than its historical 5-year average: 25.8. The (current) company valuation of Amedisys Inc. is therefore way below its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2025P/E NTM
Amedisys Inc.Free trialFree trialFree trial
International PeersFree trialFree trialFree trial
Health Care Providers10.7314.3914.10
NASDAQ 10029.3019.6418.08
United States of America0.6011.2611.23
More...
Beta (Ref: NASDAQ 100)
Levered betaUnlevered beta
1-Year0.300.31
2-Year0.180.19
3-Year0.530.54
More...
Stock Perf excl. Dividends (in USD)
AMEDNASDAQ 100Rel. Perf.
Year-to-Date5.8%-5.8%11.7%
1-Week1.5%1.3%0.2%
1-Month4.6%13.8%-9.2%
1-Year4.1%9.4%-5.3%
3-Year-17.7%55.9%-73.6%
5-Year-46.8%120.3%-167.1%
More...
International Peers - Amedisys Inc.
Company NameCtryMarket
Cap.
last (mUSD)
Amedisys Inc.USA3 125
International Peers Median0.49
Addus HomeCare Corp.USA1 941
LHC Group Inc.USAN/A
Extendicare Inc.CAN864
Chemed Corp.USA8 638
Aveanna Healthcare Hold...USA926
GPRV Analysis
Created with Highcharts 4.1.70/102/104/106/108/1010/10
Amedisys Inc.
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
Created with Highcharts 4.1.7Millions USD201920202021202220232024 (e)2025 (e)2026 (e)2027 (e)0k1k2k3k
More...
Quotes Chart

1-Year Rebased Stock Chart

  • Amedisys Inc.
  • NASDAQ 100
Created with Highcharts 4.1.7Jan '25Sep '24May '25-20%-10%0%10%20%30%
More...

Did you know ?

On the Infront Analytics platform, there are two ways to identify the listed peers which most closely resemble a private firm:
- with Peer Tracker if you already know a listed peer.
Peer Tracker is a patented technology tool for building peer groups using industry classifications. The degree of similarity between two companies is calculated comparing their sector footprints and measured using comparability scores.
- with Market Screener if you have no listed peer in mind.
Market Screener is a dedicated interface for screening companies using multiple criteria, identifying peers, searching for comparable companies in a specific business sector.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).